Ainos Q2 2026: no financials; AI Nose deployments expand; $2.1M commercial arrangement

Ainos, Inc.

2026-Q2 EPS reported -$1.05 revenue$313

No revenue or EPS figures provided in the press release; only qualitative business update.
AI Nose deployments advanced under previously announced $2.1M commercial arrangement in backend semiconductor manufacturing.
Since Dec 2025, AI Nose accumulated ~613 million industrial smell data records, primarily from semiconductor environments.
Pilot programs expanded in front-end semiconductor, industrial infrastructure, healthcare, and robotics environments.
CFO expects broader revenue generation opportunities in second half of 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.